Axithra provides rapid therapeutic drug monitoring (TDM) services at the point of need. The company focuses on saving patients' lives and improving outcomes through rapid drug monitoring, offering clinically actionable results tailored to individual patients.

Axithra

Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time. The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments.

I'm delighted to announce that we're strengthening our board of directors. Alain Pluquet, PhD and Michael Tillmann have been appointed as chairman and independent director, respectively

Axithra is hiring a talented Systems Engineer to strengthen our R&D team in Ghent. If you're interested to help shape the future of healthcare and diagnostics, please apply on our website (https://lnkd.in/eQGCcVng)

Kicking off #hellotomorrow with a very warm welcome at a great venue in Paris

Axithra is Presenting at the HealthTech Investor Summit on 6 December

Axithra is hiring! We're looking for a talented Photonics Engineer to strengthen R&D team in Ghent. If you're interested to help shape the future of healthcare and diagnostics, please apply on our website (https://lnkd.in/gsDTXc96)

Axithra is hiring! We're looking for a talented chemist to strengthen our Ghent-based R&D team. If you're interested to help shape the future of healthcare and diagnostics, please send your resume and motivation letter to hr@axithra.com

Metric
Company Name	Axithra
Symbol
MSH ID	COM:AXITHRA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Diagnostics
Country	DE
Stage
Employee Count	1
Website	axithra.com
LinkedIn	axithra
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AXIT

COM:AXITHRA

Axithra

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue